By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovery and development of novel antibody-based cancer medicines7.67M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
People's Republic of China (PRC)7.67M100.00%